Lucid Diagnostics Announces Pricing of Initial Public Offering
October 13, 2021 22:15 ET | Lucid Diagnostics Inc.
NEW YORK, Oct. 13, 2021 (GLOBE NEWSWIRE) -- Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid”) a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq:...
Global Laboratory Developed Test Market to 2028 - COVID-19 Impact and Analysis
September 27, 2021 06:33 ET | Research and Markets
Dublin, Sept. 27, 2021 (GLOBE NEWSWIRE) -- The "Global Laboratory Developed Test Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Clinical Biochemistry, Critical Care,...